BANK VONTOBEL/PUT/VERTEX PHARMACEUTICALS/400/0.1/20.09.24 | Delayed Deutsche Boerse AG 02:05:34 05/07/2024 pm IST | ||
| 0.18 EUR | -28.00% |
|
| Current month | +4.17% | ||
| 1 month | -50.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VERTEX PHARMACEUTICALS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 05/24/05 | 0.18 | -28.00% |
| 04/24/04 | 0.25 | -3.85% |
| 03/24/03 | 0.26 | +18.18% |
| 02/24/02 | 0.22 | -18.52% |
| 01/24/01 | 0.27 | +12.50% |
Delayed Quote Deutsche Boerse AG
Last update July 05, 2024 at 02:05 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | VERTEX PHARMACEUTICALS INCORPORATED |
| Issuer | 
Vontobel
|
| WKN | VM7NTP |
| ISIN | DE000VM7NTP4 |
| Date issued | 29/12/2023 |
| Strike | 400 $ |
| Maturity | 20/09/2024 (78 Days) |
| Parity | 10 : 1 |
| Emission price | 2.5 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.01 € |
|---|---|
| Lowest since issue | 0.18 € |
| Delta | -0.09x |
| Omega | 14.59 |
| Premium | 15.59x |
| Gearing | 155.14x |
| Moneyness | 0.8506 |
| Difference Strike | -70.28 $ |
| Difference Strike % | -17.57% |
| Spread | 0.2 € |
| Spread % | 52.63% |
| Intrinsic value | 0.000000 |
Company Profile
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
Ratings for Vertex Pharmaceuticals Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Vertex Pharmaceuticals Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
470.3
USD
Average target price
468.3
USD
Spread / Average Target
-0.43%
- Stock Market
- Warrants
- Warrant
